GlaxoSmithKline Consumer Nigeria Plc recently released its financial statements for the year ended December 2017. Revenue increased from ₦14.3 billion in 2016 to ₦16 billion in 2017. Profit before tax also increased from ₦185 million in 2016 to ₦1.1billion in 2017. Profit after tax fell from ₦2.3 billion in 2016 to ₦486 million in 2017.
The company has declared a special dividend of ₦7.10 per share in addition to a final dividend of ₦0.40 per share
Here is a copy of the result.
